Inmune Bio (INMB) EPS (Diluted) Growth (3y) (2024 - 2026)

Inmune Bio (INMB) EPS (Diluted) Growth (3y) (2024 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	EPS (Diluted) Growth (3y) (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	7.01%
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	12.90%
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	61.64%
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	18.44%
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	36.83%
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	36.39%
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	-26.90%
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	67.51%
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-36.81%
10	Inmune Bio	61.59 Mn	43.18 Mn	-	46.57%

Download Data